BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21538775)

  • 1. Advanced glycation end products downregulate glucokinase in mice.
    Jung H; Joo J; Jeon Y; Lee J; In J; Kim D; Kang E; Kim Y; Lim Y; Kang J; Choi J
    Diabetes Metab Res Rev; 2011 Sep; 27(6):557-63. PubMed ID: 21538775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
    J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis.
    Zhao Z; Zhao C; Zhang XH; Zheng F; Cai W; Vlassara H; Ma ZA
    Endocrinology; 2009 Jun; 150(6):2569-76. PubMed ID: 19246537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel glucokinase activator modulates pancreatic islet and hepatocyte function.
    Efanov AM; Barrett DG; Brenner MB; Briggs SL; Delaunois A; Durbin JD; Giese U; Guo H; Radloff M; Gil GS; Sewing S; Wang Y; Weichert A; Zaliani A; Gromada J
    Endocrinology; 2005 Sep; 146(9):3696-701. PubMed ID: 15919746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
    Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
    Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice.
    Winzell MS; Coghlan M; Leighton B; Frangioudakis G; Smith DM; Storlien LH; Ahrén B
    Eur J Pharmacol; 2011 Aug; 663(1-3):80-6. PubMed ID: 21586282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells.
    Lo MC; Chen MH; Lee WS; Lu CI; Chang CR; Kao SH; Lee HM
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E829-39. PubMed ID: 26394662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucokinase activation is beneficial or toxic to cultured rat pancreatic islets depending on the prevailing glucose concentration.
    Roma LP; Duprez J; Jonas JC
    Am J Physiol Endocrinol Metab; 2015 Oct; 309(7):E632-9. PubMed ID: 26264555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucose on insulin secretion, glucokinase activity, and transgene expression in transgenic mouse islets containing an upstream glucokinase promoter-human growth hormone fusion gene.
    Liang Y; Jetton TL; Zimmerman EC; Najafi H; Berner DK; Matschinsky FM; Magnuson MA
    Diabetes; 1994 Sep; 43(9):1138-45. PubMed ID: 8070614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells.
    Arden C; Hampson LJ; Huang GC; Shaw JA; Aldibbiat A; Holliman G; Manas D; Khan S; Lange AJ; Agius L
    Biochem J; 2008 Apr; 411(1):41-51. PubMed ID: 18039179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes induced by sucrose administration on glucose metabolism in pancreatic islets in normal hamsters.
    Massa ML; Borelli MI; Del Zotto H; Gagliardino JJ
    J Endocrinol; 2001 Dec; 171(3):551-6. PubMed ID: 11739021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice.
    Toye AA; Lippiat JD; Proks P; Shimomura K; Bentley L; Hugill A; Mijat V; Goldsworthy M; Moir L; Haynes A; Quarterman J; Freeman HC; Ashcroft FM; Cox RD
    Diabetologia; 2005 Apr; 48(4):675-86. PubMed ID: 15729571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of β-cell genes and improved function in rodent islets following chronic glucokinase activation.
    Gill D; Brocklehurst KJ; Brown HW; Smith DM
    J Mol Endocrinol; 2011 Aug; 47(1):59-67. PubMed ID: 21571864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose regulates glucokinase activity in cultured islets from rat pancreas.
    Liang Y; Najafi H; Matschinsky FM
    J Biol Chem; 1990 Oct; 265(28):16863-6. PubMed ID: 2211598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric activators of glucokinase: potential role in diabetes therapy.
    Grimsby J; Sarabu R; Corbett WL; Haynes NE; Bizzarro FT; Coffey JW; Guertin KR; Hilliard DW; Kester RF; Mahaney PE; Marcus L; Qi L; Spence CL; Tengi J; Magnuson MA; Chu CA; Dvorozniak MT; Matschinsky FM; Grippo JF
    Science; 2003 Jul; 301(5631):370-3. PubMed ID: 12869762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glucose-stimulated insulin release by pseudo-alpha-DL-glucose as a glucokinase inhibitor.
    Miwa I; Hara H; Okuda J; Suami T; Ogawa S
    Biochem Int; 1985 Dec; 11(6):809-16. PubMed ID: 3911958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents.
    Liang Y; Bonner-Weir S; Wu YJ; Berdanier CD; Berner DK; Efrat S; Matschinsky FM
    J Clin Invest; 1994 Jun; 93(6):2473-81. PubMed ID: 8200983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the matricellular protein Fibulin-5 as a target molecule of glucokinase-mediated calcineurin/NFAT signaling in pancreatic islets.
    Okuyama T; Shirakawa J; Yanagisawa H; Kyohara M; Yamazaki S; Tajima K; Togashi Y; Terauchi Y
    Sci Rep; 2017 May; 7(1):2364. PubMed ID: 28539593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.
    Radu RG; Fujimoto S; Mukai E; Takehiro M; Shimono D; Nabe K; Shimodahira M; Kominato R; Aramaki Y; Nishi Y; Funakoshi S; Yamada Y; Seino Y
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E365-71. PubMed ID: 15479952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator.
    Johnson D; Shepherd RM; Gill D; Gorman T; Smith DM; Dunne MJ
    Diabetes; 2007 Jun; 56(6):1694-702. PubMed ID: 17360975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.